Related references
Note: Only part of the references are listed.In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Heart Rate-corrected QT Interval Duration in Rheumatoid Arthritis and Its Reduction with Treatment with the Interleukin 6 Inhibitor Tocilizumab
Hitomi Kobayashi et al.
JOURNAL OF RHEUMATOLOGY (2018)
Drugs That May Cause or Exacerbate Heart Failure A Scientific Statement From the American Heart Association
Robert L. Page et al.
CIRCULATION (2016)
Antiarrhythmic Potential of Anticytokine Therapy in Rheumatoid Arthritis: Tocilizumab Reduces Corrected QT Interval by Controlling Systemic Inflammation
Pietro Enea Lazzerini et al.
ARTHRITIS CARE & RESEARCH (2015)
Reversal of cardiomyopathy with tocilizumab in a case of HIV-negative Castleman's disease
Louise Man et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Chloroquine cardiomyopathy - a review of the literature
Ernst Toennesmann et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2013)
Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk
Andras Varro et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Prevention of Torsade de Pointes in Hospital Settings A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation
Barbara J. Drew et al.
CIRCULATION (2010)
Antimicrobials and the Risk of Torsades de Pointes The Contribution from Data Mining of the US FDA Adverse Event Reporting System
Elisabetta Poluzzi et al.
DRUG SAFETY (2010)
Drug Interactions with New and Investigational Antiretrovirals
Kevin C. Brown et al.
CLINICAL PHARMACOKINETICS (2009)
Reversible cardiomyopathy associated with multicentric Castleman disease: Successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody
Junya Kanda et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2007)
The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters
A. Wozniacka et al.
LUPUS (2006)
Coadministration of Lopinavir/Ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction
ML Lim et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Cytochrome P4502C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes
KA Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2003)
Induced QT prolongation and torsades de pointes
YG Yap et al.
HEART (2003)
Share Paper
